Share your videos with the world

Research led by the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis. The finding offers the first evidence of a mistake that gives rise to a significant percentage of acute megakaryoblastic leukemia (AMKL) cases in children. AMKL accounts for about 10 percent of pediatric acute myeloid leukemia (AML). The discovery paves the way for desperately needed treatment advances. To view Multimedia News Release, go to http://www.multivu.com/mnr/58586-st-jude-children-s-research-hospital-gene-sequencing-childhood-leukemia

I don't know what to do. Or how to post or where to post this. My son is really sick with leukemia. I can't pay the doctors anymore I need help. If you can donate please go to this site please. http://www.gofundme.com/save-my-baby-boy

I don\'t know what to do. Or how to post or where to post this. My son is really sick with leukemia. I can\'t pay the doctors anymore I need help. If you can donate please go to this site please. http://www.gofundme.com/save-my-baby-boy

Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer. The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature. To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia

Children’s Medical Center Dallas (Children’s) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children. Pediatric strokes is a little-known condition that occurs as often as leukemia and brain tumors but often is not recognized by parents or physicians, despite the serious short- and long-term health consequences. As part of this effort, Children’s will be one of four research sites in North America participating in this groundbreaking research. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childrens/48624/